TP53 and esophageal squamous cell carcinoma: ESCC is the major histological type of esophageal cancer in Asia [2], and studies have shown that about 59–93% of ESCC patients have a TP53 mutation in genomic [3] and 23% of ESCC patients shared deregulation of Wnt/β-catenin activity [4].